Entrance Pharmaceuticals and Research Centre

Entrance Pharmaceuticals and Research Centre is a Ghanaian indigenous pharmaceutical manufacturer based in Accra, operating as the manufacturing subsidiary of the Tobinco Group. The company began operations in Q1 2014 and manufactures non-sterile preparations including anti-malarial, ARV (antiretroviral), and other essential medicines to WHO quality standards. Entrance Pharmaceuticals is led by CEO Samuel Amo Tobbin and represents one of the newer-generation Ghanaian indigenous pharmaceutical manufacturers investing in higher-grade facilities.